Coronavirus 1300 GMT 07 Mar.

A/K/A the [China, South Korea, Italy, Iran] Virus:

95% of total cases in those four countries 88% of active cases in those four countries 86% of new cases in last 24 hours in those four countries

US report: five days of 7-8 serious cases is encouraging. This stability means when a death takes someone off this list they are being replaced with a new serious patient at about the same rate. Personally sad of course but public health perspective encouraging. If serious number starts to grow it is serious.

The South Korea [serious]/[active] ratio, applied to the US, suggests about 1500 active cases in US. South Korea has best DNA testing data.

US testing is the gap between 335 ‘total cases’ reported here and the untested, asymptomatic 1165 or so because US testing is just coming on line. So expect an artificial ‘surge’ in US cases over next week as DNA evidence replaces clinical symptoms.

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest

About Dr. Quay

Steven Quay is the CEO of Atossa Therapeutics Inc. (Nasdaq:ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics for breast cancer and COVID-19. He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow in the Chemistry Department at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and spent almost a decade on the faculty of Stanford University School of Medicine. A TEDx talk he delivered on breast cancer prevention has been viewed over 200,000 times. His 300+ contributions to medicine have been cited over 9,900 times, placing him in the top 1% of scientists worldwide. He holds 87 US patents and has invented seven FDA-approved pharmaceuticals which have helped over 80 million people.

More articles:

The COVID-19 HOPE Clinical Trial​